Hypoplasia of dental enamel , including avohilmo

K11_HYPOPLASIA_ENAMEL_INCLAVO

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Primary healthcare outpatient: ICD-10 K00.40
  • Hospital discharge: ICD-10 K00.40
  • Cause of death: ICD-10 K00.40

3 out of 7 registries used, show all original rules.

1071

4. Check minimum number of events

None

1071

5. Include endpoints

None

1071

6. Filter based on genotype QC (FinnGen only)

1071

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF7

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 24724 13480 11211
Only index persons 17689 9945 7744
Unadjusted period prevalence (%)
Whole population 0.35 0.39 0.31
Only index persons 0.33 0.37 0.30
Median age at first event (years)
Whole population 11.17 11.64 10.55
Only index persons 13.49 14.09 12.72

-FinnGen-

Key figures

All Female Male
Number of individuals 1071 727 344
Unadjusted period prevalence (%) 0.22 0.25 0.15
Median age at first event (years) 18.73 21.42 13.05

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
837
Matched controls
8288
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
K00.40
ICD-10 Finland
Postnatal enamel hypoplasia
+∞
323.0
837
*
127
Kela drug reimbursment
Transplant complication
24.5
82.0
118
55
K02.0
ICD-10 Finland
Caries limited to enamel
4.2
80.9
447
1768
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
17.7
80.7
130
85
Z94.0
ICD-10 Finland
Kidney transplant status
34.7
69.8
91
29
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
29.8
69.3
94
35
H02AB09
ATC
hydrocortisone; systemic
9.5
67.7
148
184
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
11.7
61.7
119
116
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
9.6
58.2
125
149
A11CC03
ATC
alfacalcidol; systemic
19.9
56.9
87
48
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
25.3
55.8
79
34
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
6.5
54.5
153
274
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
45.0
54.5
67
16
XF602
NOMESCO Finland
Bloodpressure monitoring
22.5
49.9
73
35
B03XA01
ATC
erythropoietin; parenteral
83.3
49.4
55
7
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
27.0
49.1
68
27
137
Kela drug reimbursment
Uraemia requiring dialysis
40.6
48.7
61
16
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
5.0
47.9
170
401
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
39.2
46.7
59
16
K03.64
ICD-10 Finland
Dental calculus supragingival
2.9
46.1
437
2264
H02AB04
ATC
methylprednisolone; systemic
6.1
45.9
135
254
K03.66
ICD-10 Finland
Tooth plaque
3.7
45.6
233
774
A12AA04
ATC
calcium carbonate; oral
34.2
44.6
58
18
L04AA06
ATC
mycophenolic acid; systemic
14.0
43.0
75
58
N04.80
ICD-10 Finland
Congenital nephrotic syndrome of the Finnish type
+∞
41.9
40
*
L04AD01
ATC
ciclosporin; systemic
11.7
41.7
79
73
L04AX01
ATC
azathioprine; systemic
7.0
41.6
108
171
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
10.5
41.4
83
86
ZX120
NOMESCO Finland
Intravenous
5.0
40.9
143
328
K06.18
ICD-10 Finland
Another gingival hyperplasia
29.0
40.6
55
20
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
7.4
40.6
101
150
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
46.7
40.3
49
11
EBA15
NOMESCO Finland
Extraction of large number of teeth
9.2
40.3
87
103
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.0
40.0
296
1274
K00.41
ICD-10 Finland
Prenatal enamel hypoplasia
26.4
39.6
55
22
B05DA
ATC
Isotonic solutions
45.7
39.3
48
11
K03.00
ICD-10 Finland
Approximal wear
7.1
38.9
100
156
602
Kela drug reimbursment
Children's severe malnutrition
7.2
36.5
92
139
KAC00
NOMESCO Finland
Nephrectomy
45.8
36.1
44
10
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
39.2
35.8
45
12
5AB14
NOMESCO Finland
NA
44.7
35.1
43
10
Z99.2
ICD-10 Finland
Dependence on renal dialysis
69.2
35.1
40
6
Z49.2
ICD-10 Finland
Other dialysis
40.7
34.5
43
11
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
32.8
33.6
44
14
Z94.4
ICD-10 Finland
Liver transplant status
42.7
33.2
41
10
Z49.1
ICD-10 Finland
Extracorporeal dialysis
42.6
30.0
37
9
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.6
29.9
152
486
WX408
NOMESCO Finland
General anesthesy, balanced
2.5
29.8
312
1593
N18.8
ICD-10 Finland
Other chronic renal failure
16.2
29.6
48
31
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
9.9
29.4
60
64
K06.19
ICD-10 Finland
Gingival hyperplasia UNS
23.0
29.3
42
19
TK800
NOMESCO Finland
Hemodialysis
19.1
28.9
44
24
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
4.9
28.3
98
219
205
Kela drug reimbursment
Chronic hypertension
5.7
27.9
84
160
V03AG01
ATC
sodium cellulose phosphate; systemic
17.0
27.7
44
27
L04AA01
ATC
[U] ciclosporin; systemic
17.9
27.6
43
25
SCE00
NOMESCO Finland
Fissure closure of tooth
2.7
27.6
219
947
BE00A
NOMESCO Finland
NA
63.6
27.0
31
5
ZX199
NOMESCO Finland
Other rote
14.1
26.9
46
34
B05DB
ATC
Hypertonic solutions
35.0
26.5
34
10
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.7
26.3
212
923
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.7
26.2
209
902
RD210
NOMESCO Finland
NA
4.1
26.2
109
292
SAA04
NOMESCO Finland
Special inverstigation of mouth
3.0
26.2
173
663
SFA10
NOMESCO Finland
Fillning on one surface of tooth
2.2
26.2
547
3811
TK820
NOMESCO Finland
Peritoneal dialysis
31.8
26.0
34
11
WX882
NOMESCO Finland
High dependency care
3.6
25.9
129
404
FM2CE
NOMESCO Finland
NA
4.0
25.4
110
305
A41.9
ICD-10 Finland
Sepsis, unspecified
7.0
25.3
64
97
SAA02
NOMESCO Finland
Basic examination of mouth
3.1
25.2
759
6295
C08CA01
ATC
amlodipine; oral
4.1
24.9
102
269
TPH07
NOMESCO Finland
Cathetrisation of artery
3.7
24.8
117
349
C08CA02
ATC
felodipine; oral
10.9
24.4
47
45
F59
ICD-10 Finland
Unspecified behavioural syndromes associated with physiological disturbances and physical factors
11.7
23.8
44
39
WW500
NOMESCO Finland
Blood transfusion
6.0
23.6
67
119
XF400
NOMESCO Finland
ECG with 12 standard connections
2.6
23.2
190
828
K00.50
ICD-10 Finland
Dentinal dysplasia
20.6
23.0
34
17
XW000
NOMESCO Finland
Bone marrow biopsy
6.8
22.9
59
92
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
2.3
22.7
274
1461
4AA09
NOMESCO Finland
NA
41.0
22.7
28
7
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
4.0
22.4
95
258
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
9.2
22.4
47
53
WX110
NOMESCO Finland
Local anesthesy
2.2
22.4
647
5006
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.2
21.8
268
1435
C03CA01
ATC
furosemide; systemic
4.5
21.6
80
191
ZXA00
NOMESCO Finland
Right side
2.7
21.5
161
661
R4110
NOMESCO Finland
Physiotherapy
2.3
21.4
242
1243
Z01.2
ICD-10 Finland
Dental examination
2.0
21.2
531
3817
TPH04
NOMESCO Finland
Cathetrisation of vein
2.6
21.0
175
767
ZX121
NOMESCO Finland
Central venous catheter
10.6
20.7
40
39
XX4AW
NOMESCO Finland
NA
6.0
20.6
58
102
SDA02
NOMESCO Finland
Parodonthologic therapy
2.1
20.3
339
2059
SAA03
NOMESCO Finland
Extended examination of mouth
2.0
20.0
541
3960
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
4.2
19.9
79
202
BC00A
NOMESCO Finland
NA
25.1
19.5
27
11
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
9.6
19.1
39
42
Z94.1
ICD-10 Finland
Heart transplant status
26.5
19.1
26
10
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
2.0
19.0
542
4008
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.9
18.8
126
481
RS220
NOMESCO Finland
NA
5.6
18.3
54
101
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
2.7
18.0
139
579
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.7
18.0
82
237
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
4.9
17.8
59
126
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.5
17.6
147
640
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.9
17.4
465
3309
R50.9
ICD-10 Finland
Fever, unspecified
2.2
17.2
207
1078
V03AE01
ATC
polystyrene sulfonate; oral
31.9
17.0
22
7
RS221
NOMESCO Finland
NA
5.2
16.8
53
107
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
2.3
16.8
177
863
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
2.1
16.7
236
1315
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.0
16.6
99
350
K02.1
ICD-10 Finland
Caries of dentine
1.9
16.5
561
4300
ZXA05
NOMESCO Finland
Left side
2.6
16.5
133
567
TPX10
NOMESCO Finland
Implantation of vascular injection port
6.0
16.2
45
78
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
4.0
16.1
66
174
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.1
16.0
221
1219
C03DA01
ATC
spironolactone; oral
4.5
16.0
57
132
6BA02
NOMESCO Finland
NA
11.4
15.7
29
26
A05AA02
ATC
ursodeoxycholic acid; oral
6.0
15.6
43
74
ZXA10
NOMESCO Finland
Bilateral
2.2
15.0
168
842
EB1WA
NOMESCO Finland
NA
14.1
15.0
25
18
PA6AE
NOMESCO Finland
Ulrasound examination of neck vasculature
18.6
14.7
22
12
TK823
NOMESCO Finland
Peritoneal permeability analysis
151.1
14.4
15
*
TFC99
NOMESCO Finland
Catheterisation of heart with other procedure
6.1
14.1
38
64
3A013
NOMESCO Finland
NA
42.9
14.1
17
*
IGY02
NOMESCO Finland
Psychiatric monitoring contact
2.9
14.0
90
335
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
6.2
14.0
37
61
B03XA02
ATC
darbepoetin alfa; parenteral
15.9
13.9
22
14
SBB20
NOMESCO Finland
Tooth X-ray examination in conjunction with visit to dentist
11.6
13.8
25
22
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
4.3
13.6
51
124
KAS20
NOMESCO Finland
Allogenic transplantation of kidney from living donor
14.9
13.5
22
15
UDC00
NOMESCO Finland
Ear microscopy
2.7
13.5
94
367
K03.28
ICD-10 Finland
Other erosion of teeth
7.5
13.4
31
42
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
16.4
13.4
21
13
201
Kela drug reimbursment
Chronic cardiac insufficiency
6.1
13.3
36
61
K07.24
ICD-10 Finland
Open bite
3.7
13.1
58
164
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
40.4
13.1
16
*
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
8.9
13.0
27
31
N18.0
ICD-10 Finland
End-stage renal disease
16.9
13.0
20
12
I15.8
ICD-10 Finland
Other secondary hypertension
22.7
12.9
18
8
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
7.6
12.7
29
39
C07AB02
ATC
metoprolol; systemic
3.2
12.6
67
219
TAB00
NOMESCO Finland
Lumbar puncture
3.5
12.6
60
181
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.4
12.5
116
526
TJA33
NOMESCO Finland
Percutaneous introduction of peritoneal dialysis catheter
32.3
12.5
16
5
SAA01
NOMESCO Finland
Simple examination of mouth
1.9
12.5
664
5585
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
3.3
12.5
63
198
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
17.5
12.5
19
11
K03.29
ICD-10 Finland
Erosion of teeth occupational
8.8
12.5
26
30
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.9
12.5
207
1208
XA800
NOMESCO Finland
Neuropsychological investigation
2.6
12.3
94
387
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
5.4
12.1
36
69
C09AA02
ATC
enalapril; systemic
3.3
11.5
59
188
RK220
NOMESCO Finland
NA
8.2
11.5
25
31
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.0
11.5
178
1008
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
4.6
11.5
39
87
ZX131
NOMESCO Finland
Intrathecal
13.7
11.4
19
14
ZX114
NOMESCO Finland
Intramuscular
5.4
11.3
33
62
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
5.4
11.3
33
62
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
7.0
11.3
27
39
783
NOMESCO Finland
NA
35.2
11.2
14
*
XX4BW
NOMESCO Finland
NA
7.3
11.2
26
36
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.7
11.1
340
2400
XF622
NOMESCO Finland
Measurement of minute volume of heart
8.6
11.0
23
27
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.8
10.9
71
266
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
5.6
10.9
31
57
K03.65
ICD-10 Finland
Deposits [accretions] on teeth betel
2.1
10.7
123
619
U14
ICPC
Kidney symptom/complaint
13.0
10.6
18
14
1AB02
NOMESCO Finland
NA
10.1
10.5
20
20
B34.9
ICD-10 Finland
Viral infection, unspecified
2.5
10.4
82
344
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
6.9
10.4
25
37
J05AB01
ATC
aciclovir; systemic
2.1
10.3
128
664
TFJ02
NOMESCO Finland
Muscle biopsy of heart
16.1
10.3
16
10
WW400
NOMESCO Finland
Plasmaferesis
32.6
10.3
13
*
KAB00
NOMESCO Finland
Biopsy of kidney or pelvis of kidney
32.6
10.3
13
*
GD1LA
NOMESCO Finland
GD
23.5
10.2
14
6
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
5.0
10.2
32
66
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.1
10.1
128
667
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
4.7
10.1
33
71
D89.89
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
14.7
10.0
16
11
JJC00
NOMESCO Finland
Allogenic transplantation of liver
40.2
9.9
12
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
9.9
407
3077
WX402
NOMESCO Finland
General anaesthesia
1.9
9.7
168
989
K07.30
ICD-10 Finland
Spacing, abnormal of tooth or teeth
1.9
9.7
147
822
JAH00
NOMESCO Finland
Laparotomy
5.6
9.6
27
49
L04AA05
ATC
[U] tacrolimus; systemic
55.1
9.6
11
*
B01AA03
ATC
warfarin; systemic
3.7
9.5
40
110
KA1AE
NOMESCO Finland
Kidney ultrasound examination
5.3
9.5
28
54
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
4.7
9.5
31
67
WW200
NOMESCO Finland
Immunization
4.0
9.4
36
91
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
3.4
9.3
44
133
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.3
9.3
89
412
TK810
NOMESCO Finland
Hemofiltration
21.8
9.3
13
6
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
2.1
9.3
102
503
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
3.1
9.2
52
176
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
4.8
9.1
29
61
RL140
NOMESCO Finland
NA
4.0
9.1
35
89
GAE10
NOMESCO Finland
Closure of previous incision of chest wall
6.3
9.1
23
37
SDA04
NOMESCO Finland
Very demanding parodonthologic therapy
1.9
9.0
135
752
N04.9
ICD-10 Finland
Nephrotic syndrome, unspecified
9.1
9.0
18
20
TJW99
NOMESCO Finland
Other minor procedure in gastrointestinal endoscopy
18.7
8.9
13
7
F43.8
ICD-10 Finland
Other reactions to severe stress
3.6
8.9
39
112
N04.0
ICD-10 Finland
Nephrotic syndrome, minor glomerular abnormality
12.6
8.8
15
12
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.2
8.8
92
442
JAF10
NOMESCO Finland
Repair of umbilical hernia
6.0
8.7
23
39
Z94.2
ICD-10 Finland
Lung transplant status
50.0
8.7
10
*
B07.9
ICD-10 Finland
Verruca simplex
2.7
8.6
58
223
XF600
NOMESCO Finland
Bloodpressure measurement
2.0
8.6
107
555
1XC02
NOMESCO Finland
NA
16.3
8.5
13
8
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.6
8.5
322
2359
Z94.9
ICD-10 Finland
Transplanted organ and tissue status, unspecified
27.6
8.5
11
*
K03.0
ICD-10 Finland
Excessive attrition of teeth
3.9
8.3
33
87
D82
ICPC
Teeth/gum disease
1.6
8.2
326
2413
IEP02
NOMESCO Finland
Child-centred family therapy
3.2
8.2
41
131
A08.1
ICD-10 Finland
Acute gastroenteropathy due to Norovirus
33.4
8.1
10
*
ZX197
NOMESCO Finland
NA
33.4
8.1
10
*
K00.39
ICD-10 Finland
Indefinite enamel capacities
17.2
8.0
12
7
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
5.1
8.0
24
48
WW409
NOMESCO Finland
Other aferesis
10.1
8.0
15
15
TJD20
NOMESCO Finland
Change of gastrostomy tube
5.3
8.0
23
44
RK110
NOMESCO Finland
NA
5.9
8.0
21
36
WX002
NOMESCO Finland
Sedation and analgesia
2.0
7.9
101
531
K00.68
ICD-10 Finland
Other disturbance in the tooth eruption
2.6
7.9
57
227
RS210
NOMESCO Finland
NA
7.8
7.8
17
22
R4190
NOMESCO Finland
Nutritional therapy
2.0
7.7
101
535
2AX05
NOMESCO Finland
NA
45.0
7.7
9
*
K03.21
ICD-10 Finland
Erosion of teeth due to: persistent vomiting
45.0
7.7
9
*
Z49.0
ICD-10 Finland
Preparatory care for dialysis
15.0
7.7
12
8
RS121
NOMESCO Finland
NA
4.3
7.7
27
64
FN1BB
NOMESCO Finland
Contrast angiography of heart and/or coronary arteries after bypass surgery
5.0
7.6
23
47
K65.0
ICD-10 Finland
Acute peritonitis
11.9
7.5
13
11
C64.80
ICD-10 Finland
Wilms tumour
25.0
7.5
10
*
R63.8
ICD-10 Finland
Other symptoms and signs concerning food and fluid intake
8.9
7.5
15
17
H66.9
ICD-10 Finland
Otitis media, unspecified
1.7
7.5
189
1239
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.8
7.4
45
164
UKC02
NOMESCO Finland
Cystoscopy
2.8
7.4
47
175
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
7.7
7.4
16
21
TJF80
NOMESCO Finland
Ostomy education
6.0
7.3
19
32
K03.22
ICD-10 Finland
Erosion of teeth due to: diet
5.6
7.3
20
36
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.4
7.3
58
246
L01BB02
ATC
mercaptopurine; oral
4.4
7.3
25
58
Q23.4
ICD-10 Finland
Hypoplastic left heart syndrome
8.4
7.3
15
18
ZX090
NOMESCO Finland
Other technic of radiotherapy
8.4
7.3
15
18
N0480, Z940
ICD-10 Finland
NA
+∞
7.3
7
*
TKA05
NOMESCO Finland
Aspiration cytology of kidney
+∞
7.3
7
*
Z940, N0480
ICD-10 Finland
NA
+∞
7.3
7
*
N19
ICD-10 Finland
Unspecified kidney failure
10.9
7.3
13
12
61
HP
Catheterization and pressure measurement of the left side of the heart
15.8
7.2
11
7
324
NOMESCO Finland
NA
15.8
7.2
11
7
FQA00
NOMESCO Finland
Orthotopic transplantation of heart
15.8
7.2
11
7
3A077
NOMESCO Finland
NA
15.8
7.2
11
7
YNB20
NOMESCO Finland
Storage of stem cells for transplant
15.8
7.2
11
7
B01.9
ICD-10 Finland
Varicella without complication
3.5
7.2
32
94
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
5.1
7.1
21
42
130
Kela drug reimbursment
Malignant tumour
4.1
7.1
26
65
1XX02
NOMESCO Finland
NA
12.0
7.0
12
10
C10AA03
ATC
pravastatin; oral
5.3
7.0
20
38
WX1PA
NOMESCO Finland
Total body mineral density measurement with Dual energy X-ray absorptiometry (DXA)
6.0
7.0
18
30
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
8.8
7.0
14
16
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
1.6
7.0
182
1202
K03.2
ICD-10 Finland
Erosion of teeth
4.3
7.0
24
56
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.5
7.0
560
4765
RT150
NOMESCO Finland
NA
3.5
6.9
30
87
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
2.7
6.9
44
165
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
6.9
487
4030
QXB05
NOMESCO Finland
Skin wound assessment, unspecified location
6.1
6.7
17
28
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
6.1
6.7
17
28
ZX196
NOMESCO Finland
NA
40.0
6.7
8
*
Q44.20
ICD-10 Finland
Atresia of intrahepatic bile ducts
40.0
6.7
8
*
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
5.7
6.7
18
32
KA9AE
NOMESCO Finland
Ultrasound examination transplanted kidney
16.7
6.7
10
6
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
1.5
6.7
274
2019
K07.25
ICD-10 Finland
Anomalies of dental arch relationship
2.0
6.7
89
473
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.1
6.7
75
374
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
2.9
6.6
38
133
FXA10
NOMESCO Finland
Total cardiopulmonary bypass in deep hypothermia at concurrent surgical procedure
6.4
6.6
16
25
RK230
NOMESCO Finland
NA
5.5
6.6
18
33
C09CA01
ATC
losartan; oral
2.6
6.6
46
182
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.8
6.6
115
673
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.5
6.6
522
4402
A02BC01
ATC
omeprazole; systemic
1.7
6.5
128
777
FDF05
NOMESCO Finland
Percutaneous transluminal occlusion of aorto-pulmonary collaterals
10.0
6.5
12
12
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.6
6.5
45
177
J05AB11
ATC
valaciclovir; oral
2.2
6.4
62
289
L03AA02
ATC
filgrastim; parenteral
5.3
6.4
18
34
WW402
NOMESCO Finland
Leucoferesis
69.7
6.4
7
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.3
6.4
30
93
ZX112
NOMESCO Finland
Subcutaneous
3.9
6.3
24
62
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
6.0
6.3
16
27
FDA00
NOMESCO Finland
Aortoplasty and aorto-pulmonary shunt for HLHS
9.3
6.3
12
13
JJC50
NOMESCO Finland
Resection of transplanted liver
+∞
6.2
6
*
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.9
6.2
86
466
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.5
6.2
47
194
K06.10
ICD-10 Finland
Gingival fibromatosis
26.6
6.2
8
*
R62.0
ICD-10 Finland
Delayed milestone
2.3
6.2
55
247
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.5
6.2
219
1558
R1260
NOMESCO Finland
Evaluation of communicative skills
3.7
6.2
25
69
JDB10
NOMESCO Finland
Percutaneous gastrostomy
5.0
6.1
18
36
K83.0
ICD-10 Finland
Cholangitis
6.3
6.1
15
24
G04BE03
ATC
sildenafil; oral
5.7
6.1
16
28
Q44.29
ICD-10 Finland
Atresia of bile ducts
12.5
6.1
10
8
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
3.3
6.0
28
86
SCF03
NOMESCO Finland
Preventive oral care by dental hygienist, extensive
2.9
6.0
33
114
SCF02
NOMESCO Finland
Preventive oral care by dental hygienist
1.9
6.0
86
471
G62.0
ICD-10 Finland
Drug-induced polyneuropathy
10.0
6.0
11
11
RK320
NOMESCO Finland
NA
6.7
6.0
14
21
R11
ICD-10 Finland
Nausea and vomiting
1.9
6.0
90
503

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3026250) Tacrolimus [Mass/volume] in Blood
103
51
21.96
135.07
49.3
38.6
ug/l
6.3
7.0
1.74
96
46
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
81
28
30.83
121.12
10.4
8.0
—
—
—
0
0
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
67
15
46.99
112.50
7.9
8.6
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
69
19
38.27
110.13
6.8
6.1
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
69
19
38.27
110.13
7.1
6.4
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
137
173
8.82
101.97
18.0
6.5
u/ml
156.6
1877.1
0.63
22
15
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
75
34
23.35
101.58
8.4
9.9
mg/l
2.4
2.6
0.17
59
29
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
141
204
7.71
93.35
16.2
6.1
iu/ml
235.6
591.8
1.00
27
20
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
72
40
18.99
89.24
5.6
5.0
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
216
545
4.65
78.83
14.8
5.6
ng/l
68.5
54.9
1.69
210
526
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
217
575
4.42
74.11
35.0
13.7
mg/l
1.3
1.0
11.49
211
565
(40768446) Kidney Pathology biopsy report
60
49
12.75
60.29
3.0
2.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
85
125
7.21
54.90
2.3
1.6
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
135
322
4.59
51.95
3.8
1.7
u/ml
72.8
101.7
—
7
39
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
137
335
4.48
51.07
3.7
1.7
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
186
572
3.68
50.50
5.6
3.8
e9/l
59.3
65.7
1.71
144
362
(3037121) Protein [Mass/volume] in Urine
134
354
4.13
44.95
11.1
6.3
g/l
0.2
0.3
1.50
118
236
(3042733) HLA Ab [Presence] in Serum
45
37
12.50
44.89
3.7
3.2
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
300
1310
2.75
44.26
30.5
7.5
mmol/l
1.3
1.3
0.03
295
1246
(3027945) Reticulocytes/100 erythrocytes in Blood
219
846
2.96
40.31
11.0
5.0
%
1.3
1.4
0.56
207
799
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
224
886
2.89
39.42
7.1
2.4
%
22.1
22.6
0.23
217
812
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
148
465
3.49
38.42
3.4
1.5
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
251
1079
2.69
37.51
6.6
2.4
umol/l
13.5
14.4
1.35
245
1022
(3004789) Transferrin [Mass/volume] in Serum or Plasma
234
971
2.77
37.47
6.8
2.3
g/l
2.4
2.6
4.81
226
907
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
143
456
3.42
36.19
3.5
1.5
u/ml
204.1
182.2
0.36
95
210
(4035726)
126
381
3.57
34.57
2.4
1.5
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
97
244
4.22
34.54
2.2
1.8
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
238
1037
2.63
34.33
10.2
4.5
s
30.8
30.3
0.50
238
1022
(3026493) Urate [Moles/volume] in Serum or Plasma
233
1005
2.65
34.30
9.1
3.1
umol/l
303.4
3865.9
2.96
228
927
(3036489) Thrombin time
140
463
3.29
33.33
9.2
5.1
s
22.5
22.3
0.14
130
434
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
71
145
5.11
32.65
3.1
1.7
—
—
—
0
0
(3000991) Gas panel - Venous blood
257
1216
2.43
30.80
26.2
8.5
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
53
93
5.87
28.70
2.5
1.8
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
29
25
11.75
27.95
4.2
3.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
68
154
4.59
27.63
3.2
1.8
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
195
852
2.54
27.49
15.3
4.3
umol/l
6.1
6.1
0.01
173
693
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
62
132
4.86
27.13
3.1
1.7
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
81
215
3.94
26.74
3.5
1.9
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
57
116
5.07
26.28
4.5
3.5
umol/l
21.1
25.6
2.99
57
116
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
59
125
4.88
25.97
18.9
15.5
u/ml
0.3
0.3
1.01
40
78
(3000060) B lymphocytes [#/volume] in Blood
67
158
4.40
25.87
5.0
3.3
e6/l
201.7
341.6
2.26
47
108
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
79
212
3.89
25.67
3.3
1.8
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
68
164
4.31
25.51
5.3
3.3
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
69
171
4.19
24.98
5.2
3.2
%
67.0
70.1
0.46
69
171
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
69
171
4.19
24.98
5.2
3.2
%
7.8
9.5
1.10
59
154
(3002032) Base excess in Venous blood by calculation
264
1371
2.20
24.83
25.0
6.8
mmol/l
1.2
1.4
0.61
237
1086
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
63
149
4.37
24.23
2.2
1.5
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
68
171
4.13
24.14
5.2
3.2
—
42.7
—
0
6
(44790047)
63
153
4.26
23.42
3.1
1.8
—
—
—
0
0
(44790049)
63
153
4.26
23.42
3.1
1.8
—
—
—
0
0
(44806118)
63
154
4.23
23.22
3.1
1.8
—
—
—
0
0
(44790048)
63
154
4.23
23.22
3.1
1.8
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
202
965
2.32
23.09
4.5
2.3
nmol/l
299.7
364.6
4.86
192
913
(3011412) CD3 cells [#/volume] in Blood
70
186
3.91
23.05
5.1
3.1
e9/l
1.0
1.5
3.14
52
125
(3026782) Osmolality of Urine
287
1598
2.06
22.19
7.2
2.6
mosm/kgh2o
578.4
599.9
0.83
258
1370
(3024561) Albumin [Mass/volume] in Serum or Plasma
388
2403
1.93
22.09
16.8
5.8
g/l
37.6
38.1
1.12
377
2252
(3009214) Lutropin [Units/volume] in Serum or Plasma
155
677
2.47
21.58
2.7
2.0
u/l
5.1
6.9
2.04
108
465
(3018133) Calcium [Moles/volume] in Urine
55
131
4.32
20.96
3.1
3.6
mmol/l
2.5
2.6
0.07
50
123
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
249
1346
2.08
20.68
7.0
2.8
e6/l
0.7
0.9
1.23
181
726
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
59
154
3.95
19.91
5.2
3.2
%
24.3
26.7
0.73
59
154
(3018418) pH of Serum or Plasma
278
1583
1.99
19.90
10.6
3.4
ph
7.4
7.4
3.00
46
269
(3000850) Epithelial cells [#/volume] in Urine
287
1655
1.97
19.80
8.7
2.6
e6/l
4.6
8.4
5.87
265
1433
(3048929) Epstein Barr virus Ab [Presence] in Serum
190
942
2.21
19.64
3.1
1.5
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
156
718
2.34
19.23
2.6
1.9
iu/l
10.3
11.6
0.31
112
515
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
44
95
4.73
18.93
15.3
4.8
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
298
1770
1.92
18.69
5.2
2.5
—
—
—
0
0
(40758558) Short blood count panel - Blood
392
2541
1.83
18.65
19.8
7.4
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
174
851
2.22
18.54
7.2
2.9
g/l
9.0
9.7
1.26
167
805
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
243
1350
2.01
18.50
7.0
2.9
e6/l
2.5
3.5
1.11
176
733
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
88
311
2.96
18.49
3.8
2.3
ml/min/173m2
56.3
90.7
5.25
23
89
(42870588) Differential panel, method unspecified - Blood
488
3388
1.78
18.35
19.5
7.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
311
1886
1.89
18.23
5.5
2.9
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
40
84
4.85
17.79
1.9
1.8
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
61
178
3.53
17.54
5.1
3.0
e9/l
0.1
0.2
3.10
45
140
(3022313) Gas panel - Capillary blood
201
1063
2.07
17.44
24.4
6.2
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
61
179
3.51
17.39
5.1
3.0
e6/l
401.9
549.7
1.68
45
139
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
138
633
2.32
17.07
3.1
1.7
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
52
139
3.83
16.98
1.5
1.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
247
1420
1.93
16.86
1.9
1.7
mmol/l
1.3
1.3
0.12
241
1285
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
138
640
2.30
16.62
3.3
1.8
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
221
1232
1.97
16.48
23.9
6.3
mmol/l
1.1
1.0
0.06
171
862
(3030467) Casts [#/volume] in Urine by Automated count
351
2271
1.78
16.36
10.3
3.2
e6/l
0.1
0.2
1.83
288
1679
(3052851) Hemolysis interference index of Serum or Plasma
71
238
3.08
16.35
5.5
3.1
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
356
2314
1.78
16.33
10.0
3.1
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
24
33
7.32
16.32
2.7
1.9
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
65
207
3.24
16.30
2.6
1.8
titre
46.0
74.4
—
5
27
(3009343) pH of Capillary blood
221
1238
1.96
16.23
24.1
6.3
ph
7.4
7.4
0.73
24
46
(3028626) Oxygen [Partial pressure] in Capillary blood
199
1075
2.02
16.20
23.6
6.2
kpa
10.2
9.8
2.54
193
1032
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
47
121
3.97
16.17
2.4
1.4
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
456
3193
1.71
15.97
7.3
2.8
nmol/l
73.0
67.9
4.69
443
3010
(3051651) Icteric interference index of Serum or Plasma
40
92
4.42
15.95
6.8
4.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
341
2204
1.77
15.86
5.6
2.5
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
47
123
3.90
15.82
3.0
2.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
29
51
5.74
15.66
1.0
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
299
1866
1.81
15.61
7.7
4.0
mmol/l
7.3
8.9
5.78
280
1716
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
53
153
3.55
15.49
2.9
2.6
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
36
78
4.68
15.44
2.2
1.4
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
42
103
4.15
15.43
6.8
4.0
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
17
16
10.65
15.35
3.1
2.6
—
—
—
0
0
(3024471) HLA-A [Type]
29
52
5.63
15.35
1.0
1.0
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
354
2331
1.75
15.33
8.0
3.7
u/l
30.3
30.3
0.00
348
2224
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
94
380
2.58
15.27
2.3
1.7
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
618
4747
1.68
14.88
11.4
5.3
u/l
113.4
99.1
4.27
595
4427
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
387
2641
1.70
14.57
11.2
3.4
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
45
123
3.73
14.26
15.2
4.0
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
45
124
3.70
14.10
1.8
1.6
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
405
2821
1.67
13.98
14.0
5.6
umol/l
13.1
12.9
0.07
388
2588
(1616796) Gas panel - Central venous blood
49
145
3.45
13.81
13.4
3.5
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
152
790
2.05
13.64
2.6
1.8
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
447
3221
1.64
13.34
33.0
8.3
mmol/l
1.2
1.2
0.66
431
3023
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
456
3316
1.62
13.03
5.9
4.0
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
672
5370
1.63
13.01
8.8
3.7
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
212
1253
1.84
12.96
8.5
3.7
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
468
3433
1.62
12.85
31.4
7.8
mmol/l
1.2
1.2
0.38
436
3076
(3001122) Ferritin [Mass/volume] in Serum or Plasma
587
4549
1.61
12.81
5.1
3.0
ug/l
70.3
51.6
2.03
570
4316
(3002582) Erythrocytes [#/volume] in Urine
358
2459
1.66
12.79
11.2
3.3
e6/l
22.0
51.7
1.50
293
1843
(3001604) Monocytes [#/volume] in Blood
598
4693
1.59
12.07
20.2
7.1
e9/l
0.6
0.5
2.29
535
4005
(3006315) Basophils [#/volume] in Blood
598
4694
1.58
12.05
20.2
7.2
e9/l
0.0
0.0
3.38
536
4014
(3018095) Leukocytes [#/volume] in Urine
414
2992
1.60
11.82
12.5
3.8
e6/l
36.4
62.7
0.86
307
1954
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
20
8.01
11.72
3.3
1.5
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
614
4880
1.57
11.48
19.7
7.1
e9/l
2.1
2.2
1.06
561
4275
(3013115) Eosinophils [#/volume] in Blood
610
4848
1.56
11.35
22.1
7.7
e9/l
0.2
0.2
0.07
555
4220
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
16
21
7.62
11.27
1.3
1.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
160
905
1.88
11.14
3.2
1.8
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
284
1897
1.65
11.04
5.7
2.5
mmol/l
2.4
2.4
0.69
266
1710
(40768441) Liver Pathology biopsy report
27
61
4.46
11.03
1.9
1.6
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
131
695
1.98
11.03
2.7
1.5
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
573
4512
1.55
10.94
20.7
7.2
%
3.1
3.1
0.12
557
4274
(3007853) Bacteria identified in Skin by Aerobe culture
168
974
1.83
10.80
2.7
1.6
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
38
113
3.41
10.67
2.2
3.2
mmol/l
82.3
85.5
0.13
31
105
(3022096) Basophils/100 leukocytes in Blood
558
4384
1.54
10.66
21.0
7.4
%
0.6
0.6
0.93
544
4160
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
48
165
2.96
10.63
2.9
2.0
nmol/l
0.1
0.1
0.04
39
129
(3019069) Monocytes/100 leukocytes in Blood
575
4549
1.54
10.62
21.0
7.3
%
8.6
8.1
5.00
557
4318
(3026008) Bacteria identified in Urine by Culture
297
2026
1.62
10.55
3.8
2.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
39
119
3.32
10.52
6.4
3.6
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
589
4697
1.53
10.39
19.6
6.9
%
51.8
51.8
0.00
575
4475
(3015736) pH of Urine
408
3009
1.55
10.31
6.1
2.8
—
—
—
0
0
(21494434) Karyotype in Bone marrow
24
53
4.55
10.09
1.5
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
28
70
4.03
10.07
2.1
1.4
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
18
31
5.82
9.92
10.2
5.0
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
21
42
5.02
9.90
2.8
3.1
umol/l
1.1
1.1
0.01
21
42
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
40
129
3.14
9.88
2.3
1.8
ng/l
138.6
129.9
0.18
35
122
(3013707) Erythrocyte sedimentation rate by Westergren method
661
5436
1.53
9.86
8.5
3.8
mm/h
7.8
7.5
0.42
634
5043
(3002030) Lymphocytes/100 leukocytes in Blood
594
4778
1.51
9.83
20.3
7.1
%
33.1
33.6
0.49
578
4546
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
24
55
4.39
9.65
1.4
1.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
579
4657
1.50
9.41
7.7
3.3
u/l
29.4
28.1
0.30
556
4479
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
218
1412
1.66
9.39
7.1
2.8
mg/l
2.4
1.2
1.06
172
953
(3013650) Neutrophils [#/volume] in Blood by Automated count
629
5158
1.50
9.21
23.3
8.7
e9/l
3.5
3.6
0.92
564
4379
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
26
66
3.96
9.18
3.1
1.4
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
14
20
6.99
9.16
3.4
6.8
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
13
17
7.63
9.15
2.5
2.1
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
40
136
2.98
9.06
5.9
4.9
u/ml
4.8
12.6
0.67
40
119
(3032080) INR in Blood by Coagulation assay
249
1681
1.60
9.05
6.5
4.3
inr
1.1
1.1
0.07
55
541
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
43
153
2.85
8.98
4.5
2.2
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
30
86
3.52
8.93
2.9
1.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
31
91
3.44
8.90
2.2
1.5
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
45
165
2.77
8.90
19.2
12.9
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
523
4153
1.48
8.86
13.2
5.3
mmol/l
5.9
6.1
2.36
479
3768
(3014111) Lactate [Moles/volume] in Serum or Plasma
114
623
1.90
8.77
19.8
11.0
mmol/l
1.1
1.4
4.61
106
561
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
125
705
1.85
8.72
10.4
4.7
ng/l
1125.9
825.9
0.37
112
556
(3030905) Polymorphonuclear cells [#/volume] in Blood
45
167
2.73
8.70
6.1
3.8
e9/l
3.6
3.6
0.05
45
167
(3009261) Glucose [Presence] in Urine by Test strip
484
3796
1.47
8.67
6.9
3.0
estimate
0.0
0.0
0.00
91
719
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
684
5747
1.49
8.57
4.7
2.8
mmol/l
4.4
4.5
2.39
667
5465
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
683
5747
1.48
8.41
4.6
2.8
mmol/l
2.6
2.7
3.42
656
5400
(3021601) Nitrite [Presence] in Urine by Test strip
479
3768
1.46
8.35
9.6
4.2
estimate
0.0
0.0
0.00
92
736
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
676
5681
1.48
8.34
4.5
2.7
mmol/l
1.4
1.4
1.05
656
5367
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
45
171
2.67
8.33
7.6
4.1
%
50.9
52.5
0.34
45
171
(40767503) Oxygen content in Capillary blood by calculation
34
111
3.09
8.26
6.1
2.3
%
17.2
17.9
0.74
29
62
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
648
5407
1.47
8.25
4.5
2.6
mmol/l
1.2
1.1
0.80
626
5113
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
19
41
4.64
8.22
1.2
1.0
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
92
479
1.98
8.16
6.8
4.1
%
0.3
0.4
0.72
33
95
(3035350) Ketones [Presence] in Urine by Test strip
477
3774
1.45
7.94
7.0
3.0
estimate
0.0
0.0
0.00
85
701
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
597
4927
1.44
7.90
4.8
3.4
mmol/mol
34.7
36.7
7.26
564
4657
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
21
51
4.13
7.87
2.2
1.5
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
95
508
1.93
7.80
7.6
4.7
%
0.4
0.6
0.74
40
128
(3031040) Bacteria [#/volume] in Urine by Automated count
619
5160
1.44
7.65
8.6
3.6
e6/l
217.3
426.9
0.29
13
48
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
55
240
2.33
7.64
1.8
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
55
240
2.33
7.64
1.8
1.3
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
90
477
1.94
7.59
7.5
4.8
%
0.0
0.0
0.74
35
107
(3012501) Base excess in Blood by calculation
36
128
2.84
7.56
15.1
5.0
mmol/l
1.3
1.9
0.70
18
69
(3027315) Oxygen [Partial pressure] in Blood
36
128
2.84
7.56
15.2
4.7
kpa
10.9
9.2
6.20
36
128
(3013290) Carbon dioxide [Partial pressure] in Blood
36
128
2.84
7.56
15.2
5.0
kpa
4.8
4.9
0.53
36
128
(40768804) Tissue Pathology biopsy report
299
2178
1.49
7.53
1.8
1.8
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
179
1165
1.62
7.45
2.0
1.5
titre
348.4
536.8
1.11
31
202
(3021589) Normoblasts [#/volume] in Blood
536
4369
1.42
7.40
23.3
8.7
e9/l
0.0
0.0
0.53
453
3423
(3021960) Folate [Moles/volume] in Serum or Plasma
168
1080
1.64
7.35
1.8
1.3
nmol/l
20.0
19.2
0.34
158
954
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
22
59
3.74
7.23
1.3
1.2
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
69
339
2.08
7.19
1.7
1.4
ug/l
6.1
5.4
0.13
60
319
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
12
19
6.30
7.14
4.0
1.5
—
—
—
0
0
(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum
17
38
4.47
7.06
1.6
2.3
mg/l
3.4
4.3
—
10
29
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
55
252
2.22
6.84
1.7
1.7
nmol/l
0.3
0.3
0.43
46
214
(3017446) Testosterone [Moles/volume] in Serum or Plasma
97
550
1.82
6.66
2.6
2.1
nmol/l
11.0
9.1
0.84
78
458
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
291
2154
1.46
6.64
3.7
2.8
mg/l
2.6
2.6
0.03
260
1904
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
51
231
2.24
6.53
1.4
1.8
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
21
60
3.51
6.33
1.0
1.2
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
20
56
3.58
6.21
1.5
1.7
nmol/l
13.8
16.9
—
5
16
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
59
293
2.05
6.01
1.2
1.1
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
893
8127
1.51
5.91
17.7
7.5
u/l
25.2
24.5
0.46
881
7848
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
13
27
4.80
5.88
1.8
1.2
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
18
49
3.67
5.82
2.2
2.1
%
38.4
44.8
—
8
14
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
16
40
4.00
5.80
4.6
5.3
ug/l
227.3
188.4
0.32
16
40
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
54
264
2.07
5.74
1.6
1.5
—
387.5
—
0
8
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
11
20
5.48
5.72
4.3
1.5
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
893
8142
1.50
5.70
23.5
8.3
umol/l
66.1
62.2
2.76
893
8137
(3014148) Varicella zoster virus Ab [Titer] in Serum
54
265
2.07
5.69
1.1
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
107
655
1.68
5.64
1.4
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
69
371
1.89
5.62
6.6
3.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
207
1479
1.47
5.57
1.9
1.6
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
41
182
2.27
5.54
4.2
2.2
g/l
128.4
135.2
1.67
34
143
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
235
1723
1.44
5.53
3.9
2.5
u/l
61.7
57.2
0.34
225
1605
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
14
33
4.23
5.46
1.5
1.5
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
11
21
5.22
5.44
1.3
1.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
85
494
1.76
5.40
7.9
4.7
%
0.0
0.0
0.10
39
120
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
22
72
3.06
5.39
5.9
2.7
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
22
72
3.06
5.39
5.9
2.7
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
47
224
2.12
5.36
2.6
2.3
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
15
38
3.94
5.35
3.7
1.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
661
5750
1.35
5.34
3.1
2.6
mmol/l
5.4
5.4
0.45
625
5325
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
104
644
1.66
5.26
3.1
2.3
u/l
36.9
28.9
0.67
90
530
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
32
131
2.46
5.18
1.8
1.3
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
41
188
2.20
5.15
1.1
1.3
—
4.4
—
0
19
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
35
150
2.35
5.14
1.1
1.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
948
8804
1.55
5.01
29.2
11.3
%
38.9
39.8
4.85
847
7664
(3009871) Measles virus Ab [Titer] in Serum
13
31
4.18
5.00
1.8
2.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
57
300
1.93
4.98
2.4
1.6
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
29
116
2.51
4.94
1.1
1.3
—
57.0
—
0
5
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
11
23
4.76
4.93
11.5
4.3
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
43
206
2.11
4.86
1.1
1.3
—
39.7
—
0
13
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
315
2478
1.36
4.84
1.9
1.7
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
19
62
3.06
4.70
1.7
1.4
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
34
152
2.25
4.56
1.1
1.3
—
1.4
—
0
11
(3002256) Pathology report gross observation
101
644
1.61
4.56
1.2
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
25
97
2.58
4.54
1.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
25
97
2.58
4.54
1.0
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
25
97
2.58
4.54
1.0
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
25
97
2.58
4.54
1.0
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
25
97
2.58
4.54
1.0
1.2
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
9
11
8.14
4.52
5.3
3.3
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
10
21
4.74
4.46
4.9
2.4
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
10
21
4.74
4.46
4.9
2.4
%
8.7
8.1
—
10
21
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
25
98
2.56
4.46
1.0
1.2
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
13
34
3.81
4.45
1.9
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
13
34
3.81
4.45
1.9
1.1
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
13
34
3.81
4.45
1.9
1.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
386
3168
1.32
4.37
2.1
1.6
g/l
1.7
1.7
0.26
241
1693
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
35
163
2.16
4.28
1.7
1.4
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
9
13
6.88
4.13
2.6
1.5
—
—
—
0
0
(3011648) Oxygen content in Venous blood
25
102
2.45
4.13
25.8
19.1
%
10.4
12.0
1.65
25
102
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
11
27
4.06
4.09
1.9
2.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
389
3222
1.30
4.05
2.2
2.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
55
308
1.81
4.01
1.4
1.4
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
15
47
3.18
3.98
1.7
1.6
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
13
37
3.50
3.97
1.5
1.3
umol/l
16.1
16.4
0.06
13
37
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
912
8493
1.41
3.85
22.8
9.1
mg/l
18.8
21.2
1.80
709
5876
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
13
38
3.41
3.83
2.0
3.7
mg/l
11.9
27.7
—
6
19
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
16
54
2.96
3.77
2.6
1.5
pg
32.4
32.7
0.11
16
54
(3025941) Bacteria identified in Stool by Culture
74
459
1.64
3.77
1.4
1.2
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
67
407
1.67
3.70
17.0
12.4
mmol/l
-0.4
0.1
0.48
50
316
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
13
39
3.32
3.69
1.2
1.3
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
13
39
3.32
3.69
1.8
1.7
iu/ml
—
364710.0
—
0
5
(3022145) Colonoscopy Study observation
82
525
1.59
3.68
1.6
1.4
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
23
96
2.40
3.64
2.4
1.7
ug/l
7.6
2.1
0.56
18
82
(3019550) Sodium [Moles/volume] in Serum or Plasma
824
7578
1.32
3.58
30.1
9.2
mmol/l
139.6
139.5
0.75
806
7316
(3023419) Bacteria identified in Sputum by Culture
13
40
3.24
3.55
17.2
5.1
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
66
404
1.65
3.55
17.2
12.4
kpa
14.8
15.4
0.27
61
387
(3003338) MCHC [Mass/volume]
900
8390
1.37
3.53
30.5
11.8
g/l
334.5
334.3
0.30
893
8301
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
66
405
1.65
3.52
17.2
12.4
kpa
5.2
5.1
0.31
61
387
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
6
6
9.92
3.47
4.3
2.5
mmol/l
6.2
9.6
—
6
6
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
124
880
1.44
3.44
5.3
3.0
ng/l
560.2
888.8
0.59
71
439
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
32
158
2.03
3.42
1.3
1.3
u/ml
2.5
3.4
0.71
16
80
(40761511) CBC panel - Blood by Automated count
932
8752
1.40
3.37
15.3
7.6
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
822
7590
1.30
3.24
30.4
9.2
mmol/l
3.9
3.9
2.47
800
7285
(3024891) Influenza virus A+B Ag [Presence] in Specimen
65
407
1.61
3.22
1.7
1.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
21
90
2.33
3.17
2.1
1.8
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
8
15
5.30
3.16
2.9
1.2
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
870
8104
1.32
3.15
32.4
12.0
%
13.3
13.1
3.45
855
7955
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
116
829
1.43
3.11
1.3
1.5
pmol/l
504.0
18478685.8
0.80
108
736
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
20
85
2.35
3.08
2.3
2.1
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
13
44
2.94
3.07
1.2
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
13
44
2.94
3.07
1.2
1.6
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
13
44
2.94
3.07
1.8
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
13
44
2.94
3.07
1.8
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
13
44
2.94
3.07
1.2
1.6
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
32
165
1.94
3.06
1.1
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
18
74
2.43
2.98
1.1
1.1
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
13
45
2.88
2.96
1.5
1.7
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
31
161
1.93
2.92
1.2
1.2
u/ml
1.4
3.9
1.35
16
71
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
176
1362
1.33
2.91
3.9
2.2
u/l
325.4
311.7
0.03
168
1314
(40763480) Human metapneumovirus Ag [Presence] in Specimen
6
9
6.61
2.84
2.8
1.6
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
117
853
1.40
2.82
1.6
1.5
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
123
905
1.39
2.81
1.9
1.4
u/ml
227.1
346.1
0.87
115
844
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
16
64
2.49
2.81
1.1
1.2
%
77.2
89.0
—
9
30
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
55
343
1.62
2.80
1.7
1.5
g/l
0.2
0.2
0.10
55
331
(3010503) CD19 cells [#/volume] in Blood
11
36
3.04
2.75
4.5
2.2
e9/l
0.2
0.2
0.26
11
36
(3029937) Albumin [Presence] in Urine by Test strip
237
1924
1.28
2.74
8.1
3.1
estimate
0.0
0.0
0.80
87
720
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
16
65
2.45
2.72
1.1
1.1
%
87.4
92.2
—
9
31
(3020891) Body temperature
29
151
1.92
2.72
12.9
5.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
47
285
1.66
2.68
1.4
1.2
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
6
10
5.95
2.67
1.5
1.0
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
45
270
1.67
2.67
1.3
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
122
905
1.37
2.66
4.7
3.9
mg/l
172.8
172.0
0.00
93
691
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
8
19
4.18
2.65
1.3
1.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
59
380
1.56
2.65
1.5
1.3
—
—
—
0
0
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
9
24
3.73
2.64
1.6
1.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
28
146
1.92
2.63
5.9
2.7
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
14
55
2.53
2.56
1.9
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
44
266
1.66
2.55
1.3
1.1
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
55
352
1.57
2.54
1.7
1.5
g/l
1.1
1.2
1.52
55
337
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
9
25
3.58
2.54
1.8
2.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
181
1433
1.30
2.54
1.2
1.2
—
—
—
0
0
(40760512) CD34 cells/100 cells in Bone marrow
5
7
7.08
2.53
1.2
2.3
—
—
—
0
0
(4268621)
23
114
2.01
2.49
2.1
2.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
45
276
1.64
2.48
1.3
1.1
—
—
—
0
0
(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum
7
16
4.34
2.45
2.1
1.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
8
21
3.78
2.43
1.3
1.4
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
10
34
2.92
2.36
1.2
1.3
—
—
—
0
0
(3044889) 12 lead EKG panel
415
3634
1.21
2.35
2.8
2.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
18
83
2.16
2.35
1.2
1.1
—
—
—
0
0
(4306422)
25
131
1.91
2.34
1.2
1.2
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
7
17
4.09
2.33
1.6
1.3
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
12
46
2.59
2.30
1.5
1.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
12
46
2.59
2.30
3.4
2.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
799
7453
1.23
2.30
4.6
4.2
mu/l
1.9
1.9
0.14
768
7040
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
232
1920
1.25
2.26
1.7
1.6
pmol/l
102.1
97.4
0.97
113
1043
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
8
23
3.45
2.24
1.3
1.7
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
12
47
2.54
2.22
1.5
1.3
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
16
72
2.21
2.22
1.8
1.1
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
5
9
5.51
2.19
2.4
1.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
608
5544
1.19
2.15
12.5
6.4
ml/min/173m2
103.2
105.2
1.10
436
3880
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
13
54
2.39
2.14
1.8
1.4
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
12
48
2.49
2.13
1.7
2.7
u/ml
1444.8
953.6
0.47
12
48
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
23
122
1.88
2.10
1.7
1.3
titre
281.4
276.4
—
7
22
(3048689) Calprotectin [Mass/mass] in Stool
206
1697
1.25
2.09
4.2
3.1
ug/g
144.4
93.4
0.71
179
1326
(3003694) ABO and Rh group [Type] in Blood
349
3037
1.20
2.06
1.8
1.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
319
2753
1.21
2.06
6.8
2.8
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
5
10
4.96
2.05
1.8
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
919
8738
1.27
2.04
4.2
4.0
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
6
15
3.97
2.01
1.0
1.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
7
21
3.31
1.94
1.3
1.8
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
7
21
3.31
1.94
1.3
1.8
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
7
21
3.31
1.94
1.3
1.5
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
5
11
4.50
1.92
1.0
1.0
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
110
848
1.31
1.91
1.1
1.2
—
49.8
—
0
8
(3019060) Gas panel - Arterial blood
27
156
1.73
1.90
3.4
7.1
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
20
105
1.90
1.90
1.1
1.2
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
24
134
1.79
1.89
1.1
1.2
%
108.8
113.8
0.41
24
129
(3024731) MCV [Entitic volume]
1015
9803
1.43
1.88
32.2
13.5
fl
87.6
87.3
1.03
1003
9658
(3035941) MCH [Entitic mass]
1015
9805
1.43
1.86
32.2
13.5
pg
29.4
29.3
1.13
1003
9662
(3000570) Elastase.pancreatic [Mass/mass] in Stool
30
180
1.66
1.85
1.2
1.4
ug/g
355.5
357.6
0.02
15
95
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
19
99
1.91
1.85
1.1
1.0
g/l
1.5
1.4
0.73
19
93
(3004716) Salmonella sp identified in Stool by Organism specific culture
104
800
1.31
1.84
1.3
1.3
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
8
28
2.84
1.83
1.3
1.8
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
1015
9807
1.42
1.83
32.3
13.5
e12/l
4.5
4.6
6.75
991
9404
(40760892) CBC W Ordered Manual Differential panel - Blood
219
1843
1.22
1.82
10.8
4.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
106
819
1.31
1.82
2.2
1.9
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
6
17
3.50
1.81
1.7
1.2
u/l
231.2
195.3
—
6
17
(3007461) Platelets [#/volume] in Blood
1014
9798
1.42
1.80
32.4
13.6
e9/l
264.6
267.7
0.77
993
9414
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
41
269
1.53
1.77
1.4
1.3
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
69
502
1.38
1.76
1.7
1.8
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
15
73
2.04
1.75
1.2
1.3
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
1015
9814
1.41
1.75
32.7
13.7
g/l
131.9
134.0
5.08
1004
9677
(3010813) Leukocytes [#/volume] in Blood
1015
9815
1.41
1.74
32.3
13.6
e9/l
6.7
6.7
0.64
991
9416
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
35
224
1.56
1.70
2.4
1.8
ug/l
14.7
4.9
0.97
28
193
(3020874) Milk IgE Ab [Units/volume] in Serum
35
224
1.56
1.70
1.2
1.3
u/ml
6.6
3.8
0.33
20
140
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
15
75
1.99
1.65
1.2
1.3
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
16
82
1.94
1.64
2.2
1.4
u/ml
0.7
0.7
—
7
16
(3044290) Cell count panel - Cerebral spinal fluid
39
258
1.51
1.64
8.6
2.9
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
193
1624
1.21
1.61
1.9
2.0
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
13
62
2.08
1.61
1.2
1.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
5
14
3.54
1.60
1.6
1.6
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
5
14
3.54
1.60
2.0
1.4
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
8
32
2.48
1.57
2.9
2.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
243
2095
1.19
1.56
6.4
2.6
—
—
—
0
0
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
13
63
2.05
1.55
3.4
2.2
nmol/l
4.1
2.2
0.59
13
58
(3000012) Reticulocyte production index
7
27
2.57
1.49
1.3
1.2
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
9
37
2.41
1.47
1.4
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
7
28
2.48
1.43
1.3
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
7
28
2.48
1.43
1.3
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
7
28
2.48
1.43
1.3
1.8
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
5
16
3.10
1.42
1.4
1.3
ug/l
10.3
10.5
—
5
16
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
5
16
3.10
1.42
1.0
1.1
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
6
22
2.70
1.41
2.3
3.0
ml
641.7
635.5
—
6
14
(3006653) Thiamine [Moles/volume] in Blood
6
22
2.70
1.41
1.3
1.4
nmol/l
140.0
131.4
—
6
22
(3016750) Collection duration of Urine
6
22
2.70
1.41
2.5
2.9
min
556.2
544.5
—
6
14
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
222
1918
1.18
1.39
2.2
2.1
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
5
17
2.91
1.34
2.0
1.2
—
—
—
0
0
(3049233) Organic acids panel - Urine
0
40
0.00
1.32
0.0
1.3
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
8
33
2.40
1.30
2.9
2.3
mmol/l
106.5
105.7
—
8
33
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
10
47
2.11
1.30
1.1
1.0
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
385
3485
1.14
1.29
1.6
1.7
u/ml
3.8
2.8
0.28
55
728
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
25
159
1.57
1.29
1.1
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
11
54
2.02
1.29
1.3
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
112
916
1.23
1.26
5.6
4.5
mg/mmol
31.3
11.1
0.88
84
693
(3041354) Potassium [Moles/volume] in Venous blood
8
35
2.27
1.26
2.9
2.3
mmol/l
4.5
3.8
—
8
35
(3021387) Prolactin [Units/volume] in Serum or Plasma
92
737
1.25
1.25
1.5
1.6
mu/l
274.3
333.7
2.39
85
664
(3041806) Other cells [#/volume] in Blood by Manual count
20
122
1.63
1.22
1.5
1.7
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
6
25
2.38
1.22
1.0
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
74
914
0.78
1.22
1.2
1.3
iu/ml
98.4
150.3
0.55
24
312
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
21
130
1.61
1.22
1.5
1.3
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
32
221
1.44
1.16
1.2
1.3
u/ml
6.5
7.3
0.08
17
127
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
433
3980
1.13
1.11
2.0
2.0
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
34
241
1.41
1.08
28.9
16.0
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
700
6625
1.13
1.08
4.1
3.8
pmol/l
14.5
14.3
1.11
650
6058
(3023511) Choriogonadotropin [Units/volume] in Urine
74
591
1.25
1.06
1.6
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
202
1774
1.15
1.04
6.5
2.8
kg/l
1.0
1.0
0.36
35
295
(40768795) Lymph node Pathology biopsy report
9
45
1.98
1.04
1.1
1.2
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
9
45
1.98
1.04
2.3
2.4
umol/l
16.8
14.9
—
9
45
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
61
477
1.28
1.04
4.2
3.2
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
13
74
1.74
1.03
1.1
1.2
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
5
22
2.25
1.02
1.4
1.2
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
7
34
2.04
1.01
14.4
3.6
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
7
34
2.04
1.01
1.0
1.0
u/ml
82.1
31.1
—
7
34
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
11
60
1.82
0.99
1.2
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
11
60
1.82
0.99
1.2
1.1
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
37
271
1.36
0.99
28.1
14.7
%
0.7
0.7
0.27
37
271
(3030313) Adrenal Ab [Titer] in Serum
7
35
1.98
0.98
1.1
1.6
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
84
687
1.23
0.98
9.0
3.3
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
76
1.70
0.95
1.2
1.5
—
—
—
0
0
(3019225) pH of Specimen
48
370
1.29
0.93
7.2
3.8
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
60
478
1.25
0.90
1.4
1.5
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
29
208
1.39
0.89
2.4
1.5
g/l
0.5
0.7
0.93
24
177
(3004588) Protein electrophoresis panel - Serum or Plasma
19
126
1.50
0.87
1.2
1.6
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
60
481
1.25
0.86
1.5
1.5
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
8
43
1.84
0.86
1.0
1.2
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
38
287
1.32
0.86
8.9
2.8
mg/l
295.1
387.3
1.55
38
279
(4010399)
53
419
1.26
0.86
1.7
1.5
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
27
193
1.39
0.86
11.9
3.5
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
119
1022
1.17
0.85
1.3
1.3
titre
532.0
263.3
—
5
43
(3028679) Herpes simplex virus Ab [Presence] in Serum
14
87
1.60
0.84
1.2
1.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
17
111
1.52
0.84
1.0
1.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
128
1109
1.16
0.82
1.3
1.2
iu/ml
21.0
17.0
0.18
31
270
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
74
612
1.21
0.81
1.4
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
55
441
1.24
0.80
2.6
2.3
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
74
613
1.21
0.80
1.4
1.4
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
29
213
1.35
0.80
1.4
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
74
614
1.20
0.79
1.4
1.4
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
17
113
1.49
0.78
1.0
1.0
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
6
33
1.80
0.78
11.5
3.7
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
60
488
1.23
0.78
1.5
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
74
615
1.20
0.78
1.5
1.4
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
71
589
1.20
0.76
1.3
1.6
nmol/l
1016.9
1080.1
0.25
54
461
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
5
23
2.15
0.75
1.4
1.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
57
463
1.23
0.75
1.4
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
255
2324
1.11
0.75
1.8
1.7
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
13
82
1.57
0.75
1.5
1.8
pmol/l
389.6
356.8
—
8
67
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
10
158
0.62
0.74
1.5
1.3
pmol/l
93.1
48.8
—
10
148
(44813793)
20
140
1.42
0.73
1.1
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
6
105
0.56
0.72
1.3
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
80
675
1.18
0.72
1.5
1.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
63
520
1.21
0.72
2.1
1.9
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
45
547
0.80
0.72
2.1
2.5
—
—
—
0
0
(4062490)
21
149
1.40
0.71
1.5
1.4
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
7
40
1.73
0.70
1.9
1.2
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
5
26
1.90
0.70
1.0
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
19
133
1.42
0.70
1.7
2.0
ug/l
0.4
0.6
1.61
11
61
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
49
588
0.81
0.70
1.4
1.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
25
184
1.35
0.70
2.1
3.3
%
27.7
21.9
—
6
50
(3015076) Soybean IgE Ab [Units/volume] in Serum
24
176
1.35
0.68
1.1
1.1
u/ml
0.9
2.6
—
5
51
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
122
1070
1.14
0.68
1.0
1.1
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
17
117
1.44
0.68
1.8
1.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
7
42
1.65
0.67
2.1
1.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
79
899
0.86
0.64
1.3
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
249
2286
1.10
0.64
1.8
1.8
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
30
376
0.78
0.63
1.2
1.6
mg/l
3.4
3.9
0.21
20
244
(4027681)
13
86
1.50
0.63
1.2
1.2
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
5
29
1.71
0.63
1.2
1.9
—
—
—
0
0
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
10
62
1.60
0.62
5.1
4.1
mg/l
10.6
11.0
—
10
53
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
35
276
1.26
0.62
9.6
2.8
e6/l
4.9
15.7
0.67
29
211
(3012494) Peanut IgE Ab [Units/volume] in Serum
23
171
1.34
0.62
1.2
1.2
u/ml
3.0
23.5
0.86
13
139
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
14
95
1.46
0.61
1.0
1.1
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
35
277
1.26
0.61
9.6
2.8
e6/l
369.4
247.2
0.14
29
219
(3044941) Cell count panel - Synovial fluid
8
50
1.58
0.61
1.3
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
37
295
1.25
0.60
1.6
1.7
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
19
0.00
0.60
0.0
4.9
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
19
0.00
0.60
0.0
1.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
16
112
1.42
0.60
1.1
1.2
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
12
79
1.51
0.60
1.0
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
10
63
1.57
0.59
1.3
1.6
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
22
0.00
0.59
0.0
1.5
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
17
121
1.39
0.59
1.2
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
27
208
1.29
0.58
1.1
1.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
130
1160
1.12
0.58
1.9
1.6
%
1.4
1.3
0.37
118
1048
(3034426) Prothrombin time (PT)
6
35
1.70
0.57
1.3
1.1
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
15
105
1.42
0.57
1.2
1.5
nmol/l
32.4
32.4
0.00
15
95
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
5
88
0.56
0.56
1.0
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
16
214
0.73
0.55
1.1
1.2
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
8
123
0.64
0.54
1.0
1.0
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
17
123
1.37
0.54
1.9
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
9
59
1.51
0.54
3.6
1.7
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
21
269
0.77
0.54
1.9
2.3
nmol/l
2.0
0.5
1.31
16
231
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
31
246
1.25
0.54
2.4
3.0
ug/l
1.0
1.3
1.41
31
222
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
6
38
1.56
0.53
3.0
4.5
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
6
38
1.56
0.53
1.5
2.3
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
6
38
1.56
0.53
1.8
1.7
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
6
39
1.52
0.52
1.3
2.5
nmol/l
3.6
2.2
—
6
39
(3016650) Hepatitis A virus Ab [Presence] in Serum
21
159
1.31
0.52
1.1
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
21
266
0.78
0.51
1.1
1.6
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
12
83
1.43
0.49
1.4
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
37
304
1.21
0.48
1.9
1.6
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
7
47
1.47
0.47
1.4
1.0
—
—
—
0
0
(3000492) Spirometry study
78
685
1.13
0.47
1.6
1.4
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
68
592
1.14
0.46
2.9
3.4
pmol/l
4.9
4.9
0.07
63
546
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
7
48
1.44
0.46
1.1
1.7
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
36
297
1.20
0.46
1.5
1.5
iu/ml
0.0
0.2
0.53
14
68
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
8
115
0.68
0.46
2.0
1.6
mmol/l
6.4
6.7
—
8
72
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
33
270
1.21
0.46
9.8
2.7
mmol/l
3.2
3.4
1.12
33
256
(3029396) Erythrocyte agglutination [Presence] in Blood
7
49
1.41
0.45
4.4
3.3
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
16
119
1.33
0.45
1.0
1.0
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
33
272
1.20
0.43
3.5
2.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
6
93
0.64
0.42
1.2
1.9
—
—
—
0
0
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
5
32
1.55
0.42
1.0
1.0
g/l
171.0
161.3
—
5
32
(1002224) Polysomnography panel
24
192
1.24
0.41
1.1
1.1
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
16
203
0.78
0.41
1.9
1.9
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
105
1132
0.91
0.41
1.7
2.0
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
36
302
1.18
0.40
1.5
1.6
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
5
34
1.45
0.40
9.6
5.4
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3017461) Flecainide [Moles/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
4.1
—
0.5
—
0
18
(3044927) Protein electrophoresis panel - Urine
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
217
2026
1.07
0.39
2.0
1.9
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
13
169
0.76
0.39
1.4
1.3
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
15
114
1.30
0.38
2.0
1.5
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
5
36
1.37
0.37
1.6
1.0
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
70
766
0.90
0.37
2.1
2.6
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
80
1.36
0.36
1.5
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
32
269
1.18
0.36
1.5
1.1
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
5
77
0.64
0.35
1.0
1.2
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
9
120
0.74
0.35
2.7
2.8
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
32
270
1.18
0.35
1.4
1.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
72
1.38
0.34
1.6
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
51
566
0.88
0.34
1.7
1.7
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
13
99
1.30
0.33
1.0
1.0
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
21
248
0.83
0.31
1.1
1.1
u/ml
4.7
5.7
—
9
80
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
7
52
1.33
0.31
1.6
1.0
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
7
52
1.33
0.31
1.6
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
90
823
1.09
0.29
1.4
1.4
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
10
75
1.32
0.28
1.3
1.2
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
37
412
0.88
0.28
1.1
1.1
u/ml
2.1
7.1
3.39
20
216
(3027008) Opiates [Presence] in Urine
108
1138
0.93
0.28
1.6
2.0
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
12
93
1.28
0.27
3.7
2.4
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
13
102
1.26
0.27
1.6
1.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
80
732
1.09
0.27
2.9
1.9
mmol/l
2.4
2.4
0.05
71
613
(3016879) Cocaine [Presence] in Urine
101
1065
0.93
0.27
1.7
2.0
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
23
194
1.17
0.26
3.1
3.2
ug/l
2.1
6.2
0.84
14
125
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
70
0.70
0.26
1.4
1.2
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
118
1099
1.07
0.25
3.0
2.4
u/l
6945.9
6141.7
0.09
37
388
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
50
542
0.91
0.25
1.4
1.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
109
1142
0.94
0.25
1.6
2.0
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
22
251
0.86
0.24
1.9
1.9
iu/l
4.1
5.1
—
8
94
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
5
37
1.34
0.23
1.6
1.0
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
57
518
1.09
0.23
2.5
1.9
e9/l
4.1
4.2
0.06
51
465
(3010726) Horse dander IgE Ab [Units/volume] in Serum
58
621
0.92
0.23
1.1
1.2
u/ml
8.5
4.0
0.25
20
196
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
19
160
1.18
0.23
1.5
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
108
1126
0.94
0.22
1.6
1.9
—
—
—
0
0
(3051339) Copper [Moles/volume] in Blood
0
10
0.00
0.21
0.0
1.5
—
15.6
—
0
10
(3017704) Immunofixation for Urine
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3013931) Oligosaccharides [Presence] in Urine
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
5
42
1.18
0.21
1.6
1.0
—
—
—
0
0
(3011841) English Walnut IgE Ab [Units/volume] in Serum
8
100
0.79
0.21
1.0
1.2
u/ml
1.1
9.0
—
8
92
(3019897) Erythrocyte distribution width [Ratio] by Automated count
8
101
0.78
0.21
2.8
1.6
%
12.8
12.9
—
8
101
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
13
0.00
0.20
0.0
1.1
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
32
351
0.90
0.20
1.1
1.1
u/ml
0.4
0.6
0.22
14
137
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
14
0.00
0.20
0.0
1.8
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
14
0.00
0.20
0.0
4.2
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
9
112
0.79
0.20
1.4
1.6
pmol/l
209.9
162.7
—
9
106
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
6
49
1.21
0.20
1.5
1.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
48
437
1.09
0.19
3.9
2.3
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
33
295
1.11
0.19
1.2
1.2
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
6
52
1.14
0.19
1.7
1.1
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
7
60
1.15
0.17
1.1
1.2
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
19
213
0.88
0.17
2.8
2.0
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
66
691
0.94
0.16
1.3
1.3
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
44
468
0.93
0.16
2.7
2.5
%
33.7
33.1
0.14
35
349
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
8
68
1.16
0.16
1.0
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
42
447
0.93
0.16
1.5
1.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
112
1062
1.05
0.15
1.3
1.2
u/ml
1.7
7.9
3.16
35
371
(4094501)
9
77
1.16
0.15
1.1
1.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
9
81
1.10
0.15
1.2
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
308
2981
1.03
0.15
2.3
2.5
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
11
92
1.18
0.14
1.1
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
16
139
1.14
0.14
1.2
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
83
1.19
0.14
1.4
1.1
—
—
—
0
0
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
8
98
0.80
0.13
1.0
1.2
u/ml
13.0
3.4
—
8
90
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
50
524
0.94
0.13
1.4
1.3
miu/ml
151.0
252.0
1.17
22
263
(44816559) Phosphatidylethanol [Mass/volume] in Blood
20
219
0.90
0.13
1.4
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
85
805
1.05
0.13
2.1
2.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
154
1564
0.97
0.12
1.3
1.5
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
21
188
1.11
0.12
1.1
1.1
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
37
390
0.93
0.12
1.1
1.1
u/ml
3.7
10.7
—
5
54
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
54
561
0.95
0.11
1.3
1.2
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
61
630
0.95
0.11
1.1
1.2
u/ml
0.7
1.3
0.81
42
417
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
5
43
1.15
0.10
1.6
1.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
5
43
1.15
0.10
1.2
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
53
501
1.05
0.09
1.1
1.1
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
5
48
1.03
0.09
1.0
1.2
g/l
0.3
0.3
—
5
43
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
53
1.12
0.09
1.5
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
6
57
1.04
0.08
1.2
1.2
nmol/l
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
7
65
1.06
0.08
2.6
2.5
—
—
—
0
0
(3013512) EKG study
107
1083
0.97
0.08
3.1
2.4
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
63
644
0.96
0.08
1.2
1.2
u/ml
4.0
7.0
0.99
46
466
(3019420) Tryptase [Mass/volume] in Serum or Plasma
7
68
1.02
0.07
2.7
1.6
ug/l
4.0
5.9
—
7
61
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
6
73
0.81
0.07
1.0
1.0
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
33
343
0.95
0.07
1.7
2.0
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
36
373
0.95
0.07
1.1
1.1
u/ml
4.7
10.0
1.08
20
211
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
8
76
1.04
0.07
1.6
1.2
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
22
232
0.94
0.07
1.2
1.2
iu/ml
272.0
220.7
—
5
80
(3043409) Potassium [Moles/volume] in Arterial blood
7
79
0.87
0.07
4.0
4.3
mmol/l
3.5
3.8
—
7
68
(3006598) pH of Arterial cord blood
10
88
1.12
0.06
1.0
1.0
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
9
102
0.87
0.06
1.0
1.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
49
499
0.97
0.05
1.1
1.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
55
529
1.03
0.04
1.3
1.3
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
63
637
0.98
0.04
1.5
1.6
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
33
314
1.04
0.04
1.3
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
30
308
0.96
0.04
1.1
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
10
90
1.10
0.04
1.1
1.3
—
—
—
0
0
(4198724)
14
147
0.94
0.03
1.2
1.8
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
140
1370
1.01
0.02
2.7
2.3
ng/l
52.6
15.1
1.00
68
470
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
279
2741
1.01
0.02
2.2
2.4
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
35
338
1.02
0.01
1.5
1.3
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
70
697
0.99
0.00
1.3
1.2
u/ml
1.8
2.7
0.56
41
423
(3025130) Human papilloma virus identified in Specimen
13
132
0.97
0.00
2.0
1.7
—
—
—
0
0
(4034850)
15
144
1.03
0.00
8.9
5.9
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
19
184
1.02
0.00
2.3
1.8
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
23
222
1.02
0.00
1.9
2.0
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
128
1264
1.00
0.00
1.6
1.5
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
92
906
1.00
0.00
1.7
2.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
7
76
0.91
0.00
2.0
1.4
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
8
82
0.96
0.00
3.3
1.4
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
0
6
0.00
0.00
0.0
1.5
—
41.7
—
0
6
(3025468) Yersinia sp identified in Specimen by Organism specific culture
7
73
0.95
0.00
2.0
1.4
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3012920) Ethanol [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
6
0.00
0.00
0.0
3.0
—
—
—
0
0
(3027305) Fractional oxyhemoglobin in Arterial cord blood
0
6
0.00
0.00
0.0
1.0
—
36.5
—
0
6
(3017497) Pine Nut IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
0.0
—
0
6
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
7
73
0.95
0.00
2.0
1.4
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
5
53
0.93
0.00
1.2
1.7
mmol/l
6.8
5.5
—
5
47
(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine
0
6
0.00
0.00
0.0
1.7
—
468.0
—
0
6
(3014271) Vancomycin [Susceptibility]
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020093) Fractional oxyhemoglobin in Venous cord blood
0
6
0.00
0.00
0.0
1.0
—
78.1
—
0
6
(3012787) Ethosuximide [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
4.0
—
354.6
—
0
9
(3004616) Nuclear Ab [Presence] in Serum
6
63
0.94
0.00
1.2
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
7
77
0.90
0.00
2.0
1.4
—
—
—
0
0
(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013862) HLA-DP [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3035880) pH of Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
7
74
0.93
0.00
2.0
1.4
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
57
0.87
0.00
1.0
1.1
miu/ml
1664.8
1562.9
—
5
57
(3020191) Ethanol [Moles/volume] in Serum or Plasma
8
87
0.91
0.00
1.0
1.3
promille
1.1
1.4
—
8
70
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
6
69
0.86
0.00
1.0
1.0
—
6.8
—
0
6
(3013293) Extractable nuclear Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
0
5
0.00
0.00
0.0
11.8
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
5
56
0.88
0.00
1.0
1.1
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
7
77
0.90
0.00
2.0
1.4
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint K11_HYPOPLASIA_ENAMEL_INCLAVO and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have K11_HYPOPLASIA_ENAMEL_INCLAVO.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

Index endpoint: K11_HYPOPLASIA_ENAMEL_INCLAVO – Hypoplasia of dental enamel , including avohilmo

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data